MLB Sued Biogenesis. Now What?
Late on March 21, there were a flurry of tweets and other bits of news suggesting that Major League Baseball was about to file a lawsuit against Biogenesis, the Miami “age and wellness” clinic linked to high-profile ballplayers and performance enhancing drugs. The interwebs were alive with speculation on the claims MLB would make; there were even rumors that MLB would charge Biogenesis was part of a “RICO” conspriacy. “RICO” is the acronym for the federal law known as the Racketeer Influenced and Corrupt Practice Act, or the law used to bring down the mob.
By mid-morning on March 22, we had some answers. MLB filed a complaint in Florida state court charging Biogenesis, clinic director Anthony Bosch and others clinic associates with intentionally and wrongfully interfering with MLB’s Joint Drug Prevention and Treatment Program — a part of the collective bargaining agreement between MLB and MLBPA — by inducing certain players to purchase, use and distribute performance enhancing substances (PES). MLB claimed the Biogenesis defendants knew of MLB’s prohibition on PES from Manny Ramirez’s 50-game suspension — if not from other sources — as Biogenesis allegedly supplied Ramirez with Human Clorionic Gonadotropin, a banned substance. According to MLB, Biogenesis ignored that information and continued to supply players with prohibited PES. MLB claimed Biogenesis’ action caused the league to suffer monetary and other damages, including the loss of goodwill, revenue, and profits and harm to its reputation.